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Abstract: Mitogen-activated protein kinase (MAPK) phosphatase-3 (MKP-3) and its
substrates (extracellular signal-regulated kinase [ERK] and p38) play an important role in
pathophysiological mechanisms of acute postoperative and chronic neuropathic pain in the
spinal cord. This study aimed to understand the role of MKP-3 and its target MAPKs at the
site of surgical incision in nociceptive behavior. Wild-type (WT) and MKP-3 knockout (KO)
mice underwent unilateral plantar hind paw incision. Mechanical allodynia was assessed
by using von Frey filaments. Peripheral ERK-1/2 and p38 phosphorylation were measured
by Western blot. Cell infiltration was determined using hematoxylin and eosin histological
staining. Peripheral phosphorylated ERK-1/2 (p-ERK-1/2) inhibition was performed in
MKP-3 KO mice. In WT mice, mechanical hypersensitivity was observed on postoperative
day 1 (0.69±0.17 g baseline vs 0.13±0.08 g day 1), which resolved normally by postoperative day 12 (0.46±0.08 g, N=6). In MKP-3 KO mice, this hypersensitivity persisted at least
12 days after surgery (0.19±0.06 g; N=6). KO mice displayed higher numbers of infiltrating cells (51.4±6 cells/0.1 mm2) than WT mice (8.7±1.2 cells/0.1 mm2) on postoperative
day 1 (vs 5–6 cells/0.1 mm2 at baseline) that returned to baseline 12 days after surgery
(10–12 cells/0.1 mm2). In WT mice, peripheral p-p38 and p-ERK-1/2 expression increased
(5- and 3-fold, respectively) on postoperative days 1 and 5, and returned to basal levels
7–12 days after surgery (N=3 per group). Peripheral p-p38 levels in MKP-3 KO mice followed a similar expression pattern as WT mice. Peripheral p-ERK-1/2 levels in MKP-3 KO
mice remained elevated 12 days after surgery (2.5-fold, N=3 per group). Administration of
PD98059 (MEK inhibitor, N=8, vehicle N=9) reduced p-ERK-1/2 expression in the incised
tissue and blocked hypersensitivity in MKP-3 KO mice (N=6). The findings of this study
suggest that MKP-3 is pivotal for normal resolution of acute postoperative allodynia, through
the regulation of peripheral p-ERK-1/2.
Keywords: DUSP-6, p38, ERK
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Although effective treatment can resolve acute postsurgical pain in many patients,
30%–50% of individuals who undergo common invasive surgeries suffer persistent
postoperative pain.1 The nociceptive processes under these conditions are not fully
understood, and our knowledge on the triggers of persistent postsurgical pain is limited. Identifying these factors (ie, targets) will aid the development of more adequate
non-invasive therapies.2
Studies of pain axes in the spinal cord have shown that mitogen-activated protein
kinases (MAPKs) contribute to the initiation and maintenance of post-surgical pain.
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nociceptive behavior in mice. Based on previous studies,7,26
it is hypothesized that the dysregulation of peripheral MKP-3
will result in persistent ERK-1/2 and p38 phosphorylation
and persistent mechanical allodynia, in the mouse paw incision model.

Materials and methods
Animals
Wild-type (WT, B6129SF2/J) and MKP-3 knockout (KO,
B6129X1-Dusp6 TM1Jmol/J) male and female (50–60 days
old) mice were used (The Jackson Laboratory, Bar Harbor,
ME, USA). MKP-3 KO mice were reported to be deficient
in MKP-3 protein in the spleen, heart, lungs, and thymus
tissues.30 It was shown that MKP-3 KO mice lack MKP-3 protein in the spinal cord.7 The authors confirmed that these mice
also lack MKP-3 in the paw tissue (Figure 1). The animals
were housed individually and maintained in light-dark cycles
for 12 h with ad libitum access to food and water. All animal
procedures were done in accordance with the Guidelines for
Animal Experimentation of the International Association
for the Study of Pain and were approved by the Institutional
Animal Care and Use Committee at Dartmouth College. All
the animals (KO or WT) used for behavioral experiments
or that received treatment or that were used for tissue collection and molecular assessments were distributed using a
randomized allocation to different groups. The method used
was simple, choosing random numbers that coincide with the
identification number of the animals from a list including all
the animals of the given groups.

A
50% withdrawal threshold (g)

Inactivation of phosphorylated MAPK p38 (p-p38) successfully reduced pain-related behaviors in rodents, following
plantar incision surgery3,4 and treated postoperative pain in
humans.5 The role of MAPKs is also instrumental in chronic
pain conditions. Phosphorylation of p38 or extracellular
signal-regulated kinase (ERK)-1/2, another MAPK, is necessary for the development and perpetuation of mechanical
hypersensitivity, as observed in models of chronic neuropathic6 and acute-to-chronic postoperative pain.3,7,8 Although
p38 inhibition has demonstrated some efficacy in neuropathic
pain in humans,9,10 its role in this condition remains unclear.11
Even though the pathophysiological events in the spinal
cord are important for the maintenance of postoperative
pain,3,7,8 cellular and molecular processes at the site of the
surgical incision are also relevant. Studies on injured tissue in
rodents, following paw incision, have linked the up-regulation
of neurotrophin and cytokine genes with postoperative
pain.12 Molecular mediators such as nerve growth factor,13
lactic acid,14 prostaglandins,15 and complement factor,16 in
the incised tissue are also related to postoperative pain.
Moreover, inhibition of p-p38 and phosphorylated ERK1/2 (p-ERK-1/2), in the mouse peripheral tissue, reduced
nociceptive behaviors in a model of phorbol 12-myristate
13-acetate-induced inflammatory pain.17 Increased levels of
a downstream MAPK signaling product, interleukin 6, at
the incision site, are associated with postoperative pain in
humans18 and with the development of hyperalgesia in murine
pain models.19–21 This study proposes that a dysregulation of
the peripheral mechanisms that promote MAPK deactivation
underlies the transition from acute to persistent postoperative pain.
MAPK phosphatases (MKP) are the major negative
regulators of MAPKs. Specifically, MKP-3 preferentially
dephosphorylates p-ERK-1/2, whereas MKP-1 favors p-p38
dephosphorylation.22,23 However, their substrate preference
varies between cell types, anatomical locations, or pathological conditions.7,24 It has been demonstrated that MKPs can
act as potential analgesic targets.25,26 This study showed that
impaired MKP-3 signaling in the spinal cord leads to persistent
mechanical hypersensitivity, through dysregulation of p-p38
and p-ERK-1/2.7 Moreover, it demonstrated that spinal induction of MKP-1 prevents neuropathic mechanical hypersensitivity in rats.27 In addition to their role in the central nervous
system, MKP-1 and MKP-3 mediate peripheral inflammatory
processes.28,29 However, the contribution of MKPs at the
peripheral sites in pain conditions has not been investigated.
This study aimed to understand the role of MKPs and
their target MAPKs at the site of the surgical incision in
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Figure 1 50% paw withdrawal threshold (A) in naïve mice and mice that underwent
paw incision surgery, measured on days 1, 5, 7, and 12 in wild-type (WT, open
circles [] n=6) and in MKP-3 KO mice (closed circles [•] n=6). Data were analyzed
using two-way ANOVA + Bonferroni post hoc analysis. *P<0.05, WT vs MKP-3 KO.
Representative Western blot images (B) of hind paw plantar tissue MKP-3 and MKP1 (β-actin was used as the loading control) in WT and MKP-3 KO naïve mice. Data
are expressed as mean ± SEM.
Abbreviations: WT, wild type; KO, knockout; ANOVA, analysis of variance;
MKP-3, Mitogen-activated protein kinase phosphatase-3; SEM, standard error of
mean.
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Surgery: paw incision model of
postoperative pain
All the animals were anesthetized with isoflurane (4% induction, 2% maintenance) in oxygen, delivered through a nose
cone. Plantar aspect of the left hind paw was sterilized with
providone-iodine before and after surgeries. Approximately
0.5 cm longitudinal incision was made through skin and fascia of the plantar aspect of the left hind paw from the heel to
the base of the toes, using a No. 10 scalpel blade and sterile
technique. The plantaris muscle and ligaments were elevated
and stretched for 6–8 s (they were not incised). The wound
was cleaned and apposed with inverted 6.0 silk sutures (Ethicon Inc., Somerville, NJ, USA). The animals were allowed
to recover from the surgery for 1 h and maintained with ad
libitum access to food and water.31,32

Behavioral testing
Mechanical allodynia, measured as 50% withdrawal threshold, was assessed in the ipsilateral paw to surgery using von
Frey filaments (0.07-, 0.17-, 0.40-, 0.60-, 1.04-, 1.37-, and
2.0-g bending force) (Stoeling, Wood Dale, IL, USA) and
calculated using an up-down statistical method.3,33 In both
WT and KO animal groups, baseline behavior was tested in
naïve mice (no surgery), as well as 1, 5, 7, and 12 days after
surgery (n=6 per group; 6 males in each group). The animals
were followed up until postoperative day 12 since it had been
previously shown that paw incision-induced inflammation,
measured as paw circumference, returns to baseline levels on
day 12 after surgery.7 An additional group of MKP-3 KO mice
(n=3) was used to assess the role of MAPKs; 50% withdrawal
threshold was measured before the surgery, 12 days after
surgery, and 0.5, 1, and 2 h after intraplantar injection of an
MEK inhibitor (PD98059) that blocks phosphorylation of
ERK-1/2, administered on day 12. Two experimenters (blind
to treatment conditions) performed two sets of experiments;
the data were combined for analysis.

Cellular infiltration
Animals were anesthetized and perfused transcardially
using 0.1 M phosphate-buffered saline, followed by 4%
formaldehyde. Tissue from the operated paw was removed
in a consistent manner: the center of the incision wound
was localized, and a No. 10 blade was used to cut the soft
tissue 1.5 mm apart from the center, rostrally, and caudally.
The plantar bones determined the depth of the collected
tissue; the tissue was removed from the paw by an additional longitudinal cut above the bone of the paw. A 3 mm
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piece of plantar paw tissue was placed in 30% sucrose
solution for 48–72 h, at 4ºC. The tissue was mounted and
frozen in optimal cutting temperature compound (Sakura
Finetek, Torrence, CA, USA) at −80ºC. Hematoxylin and
Eosin (H&E) staining was performed on 20 μm paw tissue
sections, cut using Leica CM1859 Cryostat, according to
standard protocols. The stained tissues were dehydrated and
sealed with Vectashield mounting medium (Vector Labs,
Burlingame, CA, USA). Images were obtained using Q-fired
cooled CCD camera attached to an Olympus microscope
BX60. H&E staining was performed on two groups of animals (n=3 male animals per group, WT and MKP-3 KO),
prior to (naïve) and on different days after surgery (days
1, 5, 7, and 12). Three tissue sections per animal per time
point were evaluated for the number of infiltrating cells.
Three areas of 0.1 mm2 per tissue section were scored and
averaged. The percentage of polymorphonuclear (PMN)
and mononuclear cells was assessed morphologically. One
experimenter (blind to genotype conditions) performed
this analysis.

Drugs and intraplantar injections
PD98059, an MEK inhibitor used to block p-ERK-1/2
expression (Sigma-Aldrich Co., St. Louis, MO), was diluted
in dimethylsulfoxide and saline (1:1, vehicle). PD98059
(25 nmol, 8 μL), or vehicle, was injected intraplantary to the
left hind paw of MKP-3 KO mice (ipsilateral to surgery), on
postoperative day 12. The concentration of the drug was chosen
based on a previous study7 and other pain mouse models.34
Mechanical allodynia was assessed before surgery and on
postoperative day 12, prior to PD98059 injection, as well as
0.5, 1, and 2 h following drug administration. The experimenter
performed these studies blind to treatment conditions (n=9, six
males and three females in the vehicle treated group; n=8, five
males and three females in the MEK inhibitor-treated group).
Western blot was performed on six paw tissue samples, five
male mice and one female mouse, from each treatment group.

Western blot
The animals were euthanized using decapitation under isoflurane anesthesia (4% in oxygen). The plantar tissues of the
left hind paw (ipsilateral) were removed using the method
described in the “Cellular Infiltration” section. A 3 mm piece
of tissue was obtained and processed; tissue was sonicated in
PBS, with 1:1000 protease inhibitors (Sigma-Aldrich Co.).
Protein concentrations were determined by DC assay (BioRad Laboratories Inc., Hercules, CA, USA). A 50 μg protein
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sample was loaded onto sodium dodecyl sulfate (SDS) polyacrylamide electrophoresis gel (10%; Bio-Rad Laboratories
Inc.). The protein was transferred to a 0.2 μm nitrocellulose
membrane (Bio-Rad Laboratories Inc.) and processed as previously described.7 Primary antibodies used were as follows:
mouse anti-p-ERK-1/2 (1:1000), rabbit anti-p-p38 (1:1000),
mouse anti-ERK-1/2 (1:1000), rabbit anti-p38 (1:500) (Cell
Signaling Technology, Inc., Danvers, MA, USA), rabbit
anti-MKP-1 (1:500; Santa Cruz Biotechnology Inc., Dallas,
TX, USA), and rabbit anti-MKP-3 (1:3000; Cell Signaling
Technology). β-Actin was used as loading control and stained
using mouse anti-β-actin primary antibody (1:3000; Abcam,
Cambridge, MA, USA). Following primary antibody incubation (16–20 h at 4°C), the blots were washed in tris-buffered
saline (TBS) + 0.05% Tween 20 and incubated for 1 h at room
temperature in one of the following secondary antibodies:
goat anti-mouse HRP-conjugated antibody (1:3000; Bethyl
Laboratories Inc., TX, USA) or goat anti-rabbit horseradish
peroxidase (HRP)-conjugated antibody (1:3000; Pierce,
Rockford, IL, USA). Subsequently, the blots were washed
and visualized using Super Signal West Femto Maximum
Sensitivity Substrate (Pierce). Imaging was conducted using
Syngene G-Box system and software (Synoptics, Frederick,
MD, USA). Following visualization, the membranes were
incubated for 25 min at 37°C in 5% sodium azide TBS buffer
and re-probed with another primary and secondary antibody
as described previously.7 In some cases (MKP-3 and MKP-1
Western blots), β-actin blots were run simultaneously on a
different membrane using the same samples and same protein
amounts in both membranes.
Signal intensity of the protein of interest was assessed
using Image J software, and the data were quantified by dividing the intensity of the signal of the protein of interest with
the corresponding signal intensity of β-actin. Quantifications
of p-ERK-1/2 and p-p38 levels were done by normalizing
p-ERK-1/2, ERK-1/2, p-p38, and p38 against β-actin, after
which p-ERK-1/2 and p-p38 data were quantified as relative
intensity of the particular signal, divided by the previously
normalized value of total ERK-1/2 and total p38, respectively.
For the MKP-1, MKP-3, p-ERK, and p-p38 time course
quantification studies in WT and MKP-3 KO groups, two
independent experimenters (blind to genotype conditions)
performed these analyses, and both the sets of data were
combined (n=3 male mice per group).

Statistical analysis
Statistical analyses were performed using GraphPad Prism 5
(GraphPad Software Inc., La Jolla, CA, USA), and all data
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are expressed as mean ± standard error of mean (SEM). The
size of the samples was decided based on previous publications by these authors, and therefore, no a priori statistical
power calculation was conducted.7,24 Normality was tested
using Shapiro–Wilk test. Two data sets from the MEK
inhibitor (PD98059) group and one data set from the vehicle
group were identified as outliers (2-fold standard deviation)
and therefore excluded from the analysis in the behavioral
experiments.
Behavior data were analyzed using a repetitive measurement two-way analysis of variance (ANOVA) followed
by Bonferroni post hoc test; N=6. The values for cellular
infiltration measurements after the paw incision did not
follow a normal distribution and were analyzed as nonparametrical data. Kruskal–Wallis followed by a Dunn test
was performed to determine the changes in cellular infiltration against the baseline values (naïve mice) in each group.
Mann–Whitney U test was performed to compare the effects
on cellular infiltration between the KO and WT groups at
each time point; N=6. The Western blot analyses between
groups were determined by one-way ANOVA followed by
Dunnett’s post-test using the naïve group as the control,
or two-way ANOVA followed by Bonferroni’s post-test, as
appropriate, N=3. Comparison of the relative expression
of p-ERK-1/2 in PD98059-treated versus vehicle-treated
group in KO mice was performed using Mann–Whitney U
test for non-parametrical data (N=6). A P-value <0.05 was
considered statistically significant.

Results
Relationship between MKP-3 and painrelated behaviors in the mouse model of
acute postoperative pain
In both WT and MKP-3 KO mice, paw incision surgery led to
an equal level of mechanical hypersensitivity on postoperative day 1 (Figure 1A). Although the 50% withdrawal threshold in WT mice returned to baseline levels on postoperative
day 12, mechanical allodynia in MKP-3 KO mice continued
until 7–12 days after surgery (Figure 1A).
As previously demonstrated, MKP-3 KO mice did not
exhibit overtly altered behavior when compared with WT
mice.7 Development and grooming were comparable between
the two murine strains. It was confirmed that MKP-3 KO
mice did not express MKP-3 protein in the paw tissue and
that MKP-1 protein expression was consistent between WT
and MKP-3 KO mice (Figure 1B), thus excluding potential
compensatory mechanisms.
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Role of peripheral inflammation in
mechanical allodynia in WT and MKP-3
KO mice
This study evaluated the cellular infiltration levels in the paw
tissue 1–7 days after surgery and compared it with cellularity at baseline and at day 12 after surgery. H&E histological
staining in WT mice showed a significant increase in the
number of infiltrating cells on postoperative day 5 after
surgery, which remained elevated at day 7 after surgery
(Figure 2A and B). In contrast, in MKP-3 KO mice, the
number of infiltrating cells significantly increased on
postoperative day 1, in which a peak effect and a significant difference compared to the WT group was observed.
The number of cells in the KO mice declined initially but
remained significantly elevated on postoperative days 5 and 7
(Figure 2A and B). However, these values were not different
from the WT group values (Figure 2A and B). The degree
of cellular infiltration returned to basal levels 12 days after
surgery in both the groups.
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p-ERK-1/2 and p-p38 expression levels
in the paw tissue of WT and MKP-3
KO mice
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When different populations of PMN and mononuclear
cells were evaluated, it was found that the percentage of
PMN cells in the MKP-3 KO mice (86.9±2.8%) was significantly higher than that in WT mice (77.1±5.1%) 1 day
after surgery (P=0.02). A decrease in the percentage of PMN
cells was found at the later points after paw incision in both
MKP-3 KO and WT mice, but no changes in the percent
of PMN cells were found between the groups on postoperative days 5 (MKP-3 KO =31.4±5.7%, WT =22.9±3.3%
PMN cells, P=0.20) and 7 (MKP-3 KO =18.5±5.2%, WT
=13.1±2.3% PMN cells, P=0.10). The proportion of mononuclear cells was smaller than the proportion of PMN cells
on postoperative day 1 in both MKP-3 KO and WT mice,
as expected. However, a lower percentage of mononuclear
cells was obseverd on postoperative day 1 in the MKP-3 KO
group (13.1±4.0%) compared to the WT group (22.9±5.1%,
P=0.02). Conversely, a predominant proportion of mononuclear cells was observed on postoperative days 5 (MKP-3
KO =68.6±5.73%, WT =77.1±4.6% PMN cells, P=0.14)
and 7 (MKP-3 KO =81.5±5.2%, WT =86.9±2.28% PMN
cells, P=0.10) in both MKP-3 KO and WT groups, but no
significant differences were found between these groups.
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Figure 2 Representative images of H&E staining (A) (scale bar =100 µm) of paw
tissue ipsilateral to incision of wild-type (WT) and MKP-3 KO mice, in naïve mice
(left hind paw plantar tissue) and on days 1, 5, 7, and 12 after paw incision surgery.
Cellular and nuclear morphology of some cells are shown in magnified inserted
images (scale bar =20 µm). Quantification of the number of infiltrated cells (B) in
paw tissue ipsilateral to incision of wild-type (WT) and MKP-3 KO mice, in naïve
mice (left hind paw plantar tissue) and on days 1, 5, 7, and 12 after paw incision
surgery (n=3/group). The number of polymorphonuclear cells (line pattern) and
mononuclear cells (solid color) is represented within each bar. *P<0.05 vs naïve,
Kruskal–Wallis tests followed by a Dunn test; #P<0.05 WT vs MKP-3 KO, Mann–
Whitney U test. Data are expressed as mean ± SEM.
Abbreviations: H&E, hematoxylin and eosin; WT, wild type; KO, knockout; MKP3, Mitogen-activated protein kinase phosphatase-3; PMN, polymorphonuclear cells;
SEM, standard error of mean.
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Since MAPKs are the natural substrates of MKP-3, and
MAPKs determine at least in part the pro-inflammatory phenotype of immune cells, the phosphorylation level of p-ERK
and p-p38 was studied in the paw soft tissue (surgical area).
In WT mice, levels of p-ERK-1/2 protein were significantly
elevated on postoperative days 1 and 5, and no significant
differences were observed between day 7 or 12 after surgery and the naïve animals (Figure 3A and B). Similarly,
expression levels of p-p38 protein significantly increased on
postoperative days 1–5, and no statistical differences were
observed between day 7 or 12 after surgery and the naïve
groups (Figure 3A and C). These observations are consistent
with the decrease in paw edema7 and cellular infiltrates, as
well as with the resolution of mechanical allodynia in WT
mice, on days 7–12 following surgery.
In MKP-3 KO mice, p-ERK-1/2 protein levels were
significantly elevated on postoperative day 1 and remained
consistently elevated all through postoperative day 12, relative to the protein levels in naïve MKP-3 KO mice (Figure 3A
and D). On the contrary, p-p38 expression patterns in MKP-3
KO mice after paw incision surgery resembled those of WT
mice, whereas p-p38 levels increased on postoperative days
submit your manuscript | www.dovepress.com
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Figure 3 Representative Western blot images of p-ERK-1/2, total-ERK-1/2, p-p38, total-p38 and β-actin (loading control) from paw tissue of wild-type and MKP-3 KO mice,
in naïve condition and on days 1, 5, 7, and 12 after paw incision surgery (A). Quantification of p-ERK-1/2 (B) and p-p38 (C) expression in the paw tissue of wild-type mice,
and p-ERK-1/2 (D) and p-p38 (E) expression in the paw tissue of MKP-3 KO mice, in naïve condition and on days 1, 5, 7, and 12 after paw incision surgery (n=3/group). Data
were normalized to naïve condition and analyzed using one-way ANOVA + Dunnett’s post-test, *P<0.05 vs naïve. Data are expressed as mean ± SEM.
Abbreviations: ERK, extracellular signal-regulated kinase; KO, knockout; MKP-3, Mitogen-activated protein kinase phosphatase-3; ANOVA, analysis of variance; SEM,
standard error of mean.

1–7; they subsided by day 12 after surgery, relative to naïve
mice (Figure 3A and E).

MKP-3 and MKP-1 expression levels
in the paw tissue of WT and MKP-3
KO mice
In order to understand the temporal MAPK dynamics observed
in the soft tissue of the operated paw, temporal expression of
MKP-3 in WT mice and the expression of MKP-1, the other
major regulator of MAPKs, were studied. In WT mice, MKP-3
expression levels in the paw tissue increased on postoperative
days 5–7 (Figure 4A and C), in accordance with the declining expression levels of p-ERK-1/2 and p-p38 at these time
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intervals (Figure 3). Although MKP-1 expression in the WT
paw tissue initially declined on postoperative day 1, MKP-1
protein levels increased 7 days after surgery (Figure 4A and
D), potentially contributing to the return of p-p38 and p-ERK1/2 expression to basal levels on postoperative day 12.
In MKP-3 KO mice, MKP-1 expression levels in the
paw tissue increased on postoperative day 1, but returned to
baseline levels on days 5–12 after surgery, relative to naïve
mice (Figure 4B and D). The difference in MKP-1 expression
levels between WT and MKP-3 KO mice, on postoperative day 1, could be due to a compensatory mechanism in
MKP-3 KO mice following paw incision. Interestingly, the
high expression of p-p38 on postoperative day 1 is not in
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accordance with the elevation of MKP-1 protein levels in
MKP-3 KO mice, despite p-p38 being the primary MKP-1
substrate. This suggests that other factors might contribute
to the regulation of p-p38 at the early stages after surgery,
for example, MKP-3.

Effects of inhibiting ERK-1/2
phosphorylation in the paw tissue of
MKP-3 KO mice
This study observed that p-ERK-1/2 expression levels
remained elevated in the paw tissue of MKP-3 KO mice
on postoperative day 12, contrary to the unchanged p-p38
levels, relative to naïve mice (Figure 3D and E). To test a
potential causative association between persistent p-ERK
and persistent allodynia, the effect of inhibiting MEK was
studied, which subsequently prevents ERK phosphorylation,
in the paw tissue, on mechanical allodynia in MKP-3 KO
mice, 12 days after surgery.
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It was also observed that local intradermal administration
of a small molecule MEK inhibitor, PD98059 (25 nmol), partially, but significantly, reversed incision-induced persistent
mechanical allodynia 1–2 h after injection, compared to the
vehicle-treated group (Figure 5A). To confirm the inhibitory
effects of PD98059 over p-ERK-1/2, its expression levels
after treatment were measured. A partial but significant
reduction in p-ERK-1/2 expression was observed in the paw
tissue 2 h after treatment, compared to the vehicle (Figure 5B
and C). These data strongly suggest a causative relationship between peripheral p-ERK expression and persistent
postoperative hypersensitivity observed in MKP-3 KO mice.

Discussion
This study demonstrates that lack of MKP-3 protein in mice
leads to a long-lasting phosphorylation of MAPK ERK-1/2
in the peripheral tissue following a surgical intervention
(paw incision), which results in persistent postoperative
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 echanical allodynia. The major novelty of this study is
m
therefore the discovery of the important role that MKP-3
plays in the periphery in the transition from acute to chronic
postoperative mechanical hypersensitivity.
It has been previously shown that dysregulation of MKPs
in the spinal cord is associated with chronic neuropathic
pain, such that MKP-1 and MKP-3 induction in the spinal
cord reduced mechanical allodynia in the rat model of neuropathic pain.26,27 In a more recent study, a mouse model
of acute postoperative pain was used, that is, paw incision
surgery, to demonstrate that MKP-3 also plays a role in the
transition from acute to chronic postoperative mechanical
allodynia through mechanisms in the spinal cord.7 Using
the same model, this study aimed to understand the role of
MKP-3 in the mechanisms governing persistent mechanical
hypersensitivity in the peripheral tissue, as a more clinically
relevant, accessible, and feasible treatment site.
This study confirms that lack of MKP-3 does not alter
nociceptive behaviors in mice in response to mechanical
stimulation under normal conditions. Moreover, the absence
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of MKP-3 does not influence the extent of acute mechanical
allodynia (postoperative day 1). Nonetheless, lack of MKP-3
influences the transition from acute to chronic postoperative
hypersensitivity. These data indicate that the function of
MKP-3 in the peripheral injured tissue is minimal in nociceptive basal tone and the early stages of postoperative hypersensitivity. However, under normal conditions, peripheral MKP-3
seems to play a key role in the resolution phase of postsurgical
mechanical allodynia by dephosphorylating p-ERK. This is
supported by the temporal pattern of expression of peripheral
MKP-3 and p-ERK following paw incision in WT animals.
For example, expression levels of paw p-ERK decline as
postoperative allodynia resolves in WT mice (postoperative
days 7–12). This temporal pattern correlates well with the
expression of MKP-3 in the injured tissue in these mice, which
increases on postoperative days 5–7 and returns to baseline on
day 12. This assumption is confirmed by the fact that the lack
of MKP-3 (KO mice) results in a persistent p-ERK expression in the injured tissue. These findings show that MKP-3
controls p-ERK dephosphorylation in the incision area and
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thus promotes the resolution of postoperative hypersensitivity
in acute postoperative pain.
The current study also uncovers a differential substrate
preference of MKP-3 between the periphery and the spinal
cord in mice. Even though MKP-3 can modulate different
MAPKs, MKP-3 preferentially dephosphorylates p-ERK
in most systems.22,23 It has been previously demonstrated
that MKP-3 in the spinal cord modulates both p-ERK and
p-p38 to a similar extent,7 and furthermore that MKP-3
preferentially dephosphorylates m-JNK (another major
MAPK) in the rat brain-derived astrocytes.24 Together,
these data strongly suggest that the substrate preference of
MKP-3 is determined by the relevance of a given MAPK
in a given tissue. This is consistent, for example, with the
prominent role of p-JNK in astrocytic function.35,36 Herein,
this study observed that the temporal pattern of expression
of peripheral p-p38 following paw incision was not altered
in MKP-3 KO mice when compared to WT mice. In other
words, p-p38 is dephosphorylated at the time of resolution
of postoperative allodynia even in the absence of MKP-3.
Therefore, the current results demonstrate that MKP-3 preserves its selectivity for p-ERK at the periphery, since the
lack of MKP-3 (KO mice) resulted in persistent expression
of p-ERK that paralleled the persistent mechanical hypersensitivity in these mice. This study confirms the functional
association between the lack of MKP-3, persistent p-ERK
expression in the peripheral injured tissue, and the maintenance of postoperative mechanical hypersensitivity using
an MEK inhibitor. Accordingly, phosphorylation of ERK in
the peripheral tissues during inflammation contributes to the
pain-related behaviors in several rodent models.37–39 Since
the findings indicate that persistent p-ERK expression on
postoperative day 12 is not associated with cell infiltration
(resolved at this time point), these data suggest that this
MAPK phosphorylation takes place in non-immune cells,
namely nerve fibers or skin cells. It has been demonstrated
that an elevation of p-ERK expression in epidermal and
dermal peripheral nociceptors (C-fibers) is responsible for
capsaicin-induced thermal and mechanical hypersensitivity.40,41 An increase in p-ERK-1/2 and p-p38 expression
as well as a functional association between the two have
been observed in keratinocytes of psoriatic lesions in
humans42–44 and in mouse keratinocytes under pruritogenic
conditions.45 Furthermore, p-ERK expression is enhanced
in human keratinocytes in in vitro models of acute and
chronic wounds.46,47 The phosphorylation of ERK can also
be induced by pro-algesic factors such as epidermal growth
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factor.47 Since ERK phosphorylation induces the production
of pro-algesic factors by non-neuronal cells that sensitize
peripheral nociceptors, which in turn are characterized by
neuronal ERK phosphorylation,6 it is likely that the results
are explained by a pronociceptive feedback loop of skin cell
and peripheral nociceptor ERK phosphorylation.
The findings of this study indicate that, although some
aspects of the neuroinflammatory process might resolve in
a timely fashion, following a peripheral insult, they might
not be indicative of a complete resolution of the peripheral
mechanisms underlying the transition from acute to chronic
pain. It is plausible that the magnitude of the early cellular
infiltration contributes to the persistent elevation of p-ERK
in the periphery (nociceptors and/or skin cells) and subsequently to the transition from acute to chronic pain in MKP-3
KO mice. Immunohistochemistry staining to determine the
specific repertoire of immune cells might better elucidate the
role of immune cell infiltration in the resolution of postoperative pain. Whether the MAPK/MKP signaling pathway
pattern could be used as a biomarker to identify potential
patients at risk of developing chronic postoperative pain, or
those already suffering from it, remains to be studied. It is
certainly a testable hypothesis (minimal required invasiveness
for assessment) that deserves further study. These studies in
human tissue would move forward the field to set a rationale
for potential studies with already available p-ERK inhibitors
(some already evaluated in clinical trials for osteoarthritis
or cancer).48,49
This study also suggests that p-ERK, even though it promotes a cellular pro-inflammatory phenotype, does not seem
to play a role in cellular infiltration. On the other hand, p-p38
seems to be functionally associated with the initiation and
resolution of cell infiltration, because of the similar pattern
of appearance of these phenomena in both WT and MKP-3
KO groups. These hypotheses are in line with previous
observations, in which the intraarticular inhibition of p-p38
or p-JNK, but not p-ERK, reduced cellular infiltration into
the synovium, in a carrageenan-induced arthritis rat model.50
Therefore, this study does not rule out the potential role of
peripheral p-p38 in the transition from acute to chronic pain.
Similarly, the role of MKP-1 (which preferentially dephosphorylates p-p38) in the peripheral mechanisms of chronic
pain cannot be ruled out. Elevated MKP-1 expression in
MKP-3 KO mice on postoperative day 1 could suggest a
compensatory mechanism triggered by surgical incision
and the initial events of postoperative hypersensitivity. The
high levels of p-p38 expression in the presence of elevated

submit your manuscript | www.dovepress.com

Dovepress

771

Dovepress

Skopelja-Gardner et al

MKP-1expression in the early stages of acute postoperative
pain in MKP-3 KO animals suggest that other factors, besides
MKP-1, might be involved in p38 regulation. Based on the
observation that p-p38 dephosphorylation associates with the
resolution of inflammation, it is speculated that inflammatory
mediators could be involved in p38 modulation.
The role of MAPKs, such as p-ERK, in chronic pain
models is well recognized.6,51 Activation of MAPKs is
required for effective production of pro-algesic factors that
sensitize peripheral nociceptors and subsequently perpetuate MAPK phosphorylation, leading to central sensitization
and establishment of chronic pain.27 The induction of an
effective MKP activity could break this cycle and interrupt
the molecular signals driving the transition to chronic pain.
It has been demonstrated that novel approaches could be
utilized to develop gene therapies, for example, induction
of MKP expression to modulate cell phenotype and treat
chronic pain.27 The induction of MKPs can also be achieved
by pharmacological approaches. For example, glucocorticoids52 or cannabinoids26 produce anti-inflammatory effects
by inducing MKP-1 and/or MKP-3. Curiously, the use of
glucocorticoids in surgical patients seems to reduce the use
of analgesics in postoperative pain.53,54
Although this study focused on peripheral MKP-3 and
MAPK molecular changes in the context of postoperative
pain resolution, it recognizes that multiple factors, such as
genetics,55,56 preoperative pain and physiological states,57
psychological vulnerability,58 and surgical techniques,59 contribute to post-surgical pain and its persistence. It warrants
further investigation on the potential association of these
factors with the abovementioned pathways.

Conclusion
This study revealed that MKP-3/p-ERK-1/2 signaling in
the periphery greatly influences the transition from acute
to chronic postoperative pain. The current data further support the notion that biochemical and regulatory properties
of MKP-3 render it a promising target for preventing and
treating chronic postoperative pain. Moreover, studies by
the authors uncover the possibility of intervening at the site
of surgery, which provides a more feasible therapeutic site
than the central nervous system.60
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